General Information of the Compound
| Compound ID |
CP0701289
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,5-dimethoxyphenyl)-N-(3-((2S,5S)-2,5-dimethylpyrrolidin-1-yl)propyl)-3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H37ClN6O2
|
||||||||||||||||||
| Molecular Weight |
537.108
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H36N6O2.ClH/c1-20-7-8-21(2)34(20)11-6-12-35(24-13-25(36-4)16-26(14-24)37-5)23-9-10-27-28(15-23)32-29(18-30-27)22-17-31-33(3)19-22;/h9-10,13-21H,6-8,11-12H2,1-5H3;1H/t20-,21-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NQEIXHXOMZOMCJ-GUTACTQSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2